课题基金 / 基金详情

Novel imaging strategies to investigate 3D tumour invasion at the molecular level

Novel imaging strategies to investigate 3D tumour invasion at the molecular level
在分子水平研究 3D 肿瘤侵袭的新颖成像策略
批准号:
MR/T04067X/1
负责人:
Simon Poland
金额:
$124.48万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2020
资助国家:
英国
项目状态:
未结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer is the one of the major causes of deaths worldwide and despite our increased understanding and the development of more improved treatments, many advanced cancers are still incurable. The majority of these deaths are due to metastasis whereby through cascading events, cancer cells escape the primary tumour, acquiring cellular characteristics which enable them to colonise other parts of the body. Several underlying mechanisms of this process are not understood and require the development of new biological models which can mimic cellular interactions within these complex tumour ecosystems. Until now most of our understanding of the basic molecular principles of cancer have come from experimentation with single layer 2D cell culture models. Whilst inexpensive and easy to image, they are not representative of the way cells actually interact in an in vivo environment. 3D cell cultures (i.e. spheroids), have gained great significance in recent years as they can provide a much more realistic environment to simulate biological interactions. Unfortunately as the relative size, heterogeneity and hence complexity of these 3D cell cultures increases, it imposes severe limitations when imaging with any optically based technique. Local variations in refractive index induce optical aberrations and scattering, and coupled with absorption, lead to severe a degradation in optical resolution, as well as a loss in signal and contrast. The key objective of this fellowship is to develop novel optical imaging strategies which will enable for the first time, the complete interrogation of tumour derived spheroid models, to understand how cancer cells to dissociate from the primary tumour, evade immune surveillance and invade surrounding tissues. The imaging platform will be based on light sheet fluorescence microscopy (LSFM) to enable high-speed volumetric imaging capability. Building on previously conducted research at King's College London, the system will incorporate fluorescence lifetime imaging (FLIM) to allow functional information to be extracted, which will be instrumental in gaining an understanding of the molecular interactions taking place. Several aspects of the design will be considering including the incorporation of adaptive optical elements (i.e. spatial light modulator) to counteract aberrative effects in both the illumination and detection paths. Using this technology and working in close collaboration with a number of life scientists, tumour spheroid cultures will be constructed to closely imitate the tumour microenvironment (TME). Several aspects of this TME will be examined including (i) cell motility and migration of cancer cells and (ii) their effects on the structural modelling of the extra cellular matrix (iii) the role of immune cells in tumour progress.Analysis of this multivariate and multidimensional data represents a huge challenge and a number of conventional machine learning and deep learning techniques will be explored. The development of instrumentation to image, extract, and analyse functional information of large 3D cell culture models non-invasively, at high-speed and at high resolution is vital and will further improve our understanding of cellular complexities of interactions between cells and the Extracellular Matrix (ECM). This will serve to assist in the construction of more complex spheroid structures to mimic in vivo conditions and has enormous potential to aid in the development on specific anti-cancer therapies, revolutionising patient treatments and outcomes.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Small molecule PD-L1 inhibitor modulates expression of PD-L1 on the cell surface - a potential mechanism of blocking interaction with PD-1
小分子 PD-L1 抑制剂调节细胞表面 PD-L1 的表达——阻断与 PD-1 相互作用的潜在机制
DOI: 10.1016/s0959-8049(22)00989-3
发表时间: 2022
期刊: European Journal of Cancer
影响因子: 8.4
作者: [Weitsman G]
通讯作者: Weitsman G
DOI: 10.1038/s41467-021-25916-6
发表时间: 2021-09-28
期刊: Nature communications
影响因子: 16.6
作者: [Law AL, Jalal S, Pallett T, Mosis F, Guni A, Brayford S, Yolland L, Marcotti S, Levitt JA, Poland SP, Rowe-Sampson M, Jandke A, Köchl R, Pula G, Ameer-Beg SM, Stramer BM, Krause M]
通讯作者: Krause M
Development of a high-speed line-scanning fluorescence lifetime imaging microscope for biological imaging.
开发用于生物成像的高速线扫描荧光寿命成像显微镜。
DOI: 10.1364/ol.482403
发表时间: 2023
期刊: Optics letters
影响因子: 3.6
作者: [Mai H]
通讯作者: Mai H
Development of a high-speed confocal line scanning FLIM microscope for live cell imaging (Conference Presentation)
开发用于活细胞成像的高速共焦线扫描 FLIM 显微镜(会议演示)
DOI: 10.1117/12.2650206
发表时间: 2023
期刊:
影响因子: --
作者: [Poland S]
通讯作者: Poland S
国内基金
海外基金
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张淼
  • 依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
  • 批准号:
    82372015
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    熊丽琴
  • 依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
  • 批准号:
    82371912
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    吴广宇
  • 依托单位:
神经系统中大麻素CB1受体与周期性细胞骨架相互作用的机制和功能研究
  • 批准号:
    32100555
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李卉
  • 依托单位: